The BH3 Mimetic ABT-737 Increases Treatment Efficiency of Paclitaxel Against Hepatoblastoma

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-11-362
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The BH3 Mimetic Drug ABT-737 Induces Apoptosis and Acts Synergistically With Chemotherapeutic Drugs in Thyroid Carcinoma Cells

Cancer Cell International
Cancer ResearchOncologyGenetics
2016English

BCL-xL-Inhibitory BH3 Mimetics (ABT-737 or ABT-263) and the Modulation of Cytosolic Calcium Flux and Platelet Function

Blood
BiochemistryImmunologyCell BiologyHematology
2012English

Comparison of Putative BH3 Mimetics AT-101, HA14-1, Sabutoclax and TW-37 With ABT-737 in Platelets

Platelets
MedicineHematology
2020English

Synergistic BCL-2 Inhibition by ABT-737 and Cyclosporine A

Apoptosis : an international journal on programmed cell death
Cell BiologyPharmacologyBiochemistryClinical BiochemistryCancer ResearchPharmaceutical Science
2012English

Increased Lymphocyte Apoptosis in Mouse Models of Colitis Upon ABT-737 Treatment Is Dependent Upon BIM Expression

Clinical and Experimental Immunology
AllergyImmunology
2015English

ABT-737, a Small Molecule BCL-2/BCL-xL Antagonist, Increases Antimitotic-Mediated Apoptosis in Human Prostate Cancer Cells

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2013English

BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines

Cancer Cell
Cancer ResearchOncologyCell Biology
2018English

Synergistic Killing of Human Small Cell Lung Cancer Cells by the BCL-2-Inositol 1,4,5-Trisphosphate Receptor Disruptor BIRD-2 and the BH3-mimetic ABT-263

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2015English

Microfluidic Profiling of Apoptosis-Related Genes After Treatment With BH3-mimetic Agents in Astrocyte and Glioblastoma Cell Lines

Oncology Reports
MedicineCancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy